Clinical Trial Update: Gene Therapy for Blindness Caused by Choroideremia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial update reports on a gene therapy being assessed for blindness caused by choroideremia, conducted by the University of Oxfor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroideremia

Drugs mentioned

• Choroideremia gene therapy

Snippet

Sponsor: University of Oxford | Conditions: Choroideremia | Phase 1, Phase 2 | Status: COMPLETED